Devroe Eric 4
4 · Acrivon Therapeutics, Inc. · Filed Aug 16, 2024
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2024-08-14$7.02/sh−613$4,303→ 68,484 total
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.